drugset / Trial / NCT00332579

Double-Blind Naltrexone in Kleptomania

NCT00332579

Phase 2 Completed 25 enrolled University of Minnesota
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania.

Timeline

Start
2006-05-01
Primary completion
2008-09-01
Completion
2008-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg Oral
Comparator Naltrexone Small molecule 150 mg Oral

Indications